Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|October 28, 2021
Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Ambrosia Simmons, D Nathan Kim, et al.Journal of the American College of Radiology : JACR|May 13, 2022
ACR Appropriateness Criteria® Imaging of the Axilla, Huong T Le-Petross, Priscilla J Slanetz, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2004
HER-2 gene amplification can be acquired as breast cancer progressesSongdong Meng, Debasish Tripathy, Sanjay Shete, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Circulating tumor cells in patients with breast cancer dormancySongdong Meng, Debasish Tripathy, Eugene P Frenkel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.JAMA Network Open|November 14, 2025
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical TrialAsal Rahimi, Marilyn Leitch, Basak Dogan, et al.JAMA|October 9, 2013
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trialJudy C Boughey, Vera J Suman, Elizabeth A Mittendorf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.JAMA Oncology|January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical TrialCynthia X Ma, Vera J Suman, Souzan Sanati, et al.Pageof 8